Please login to the form below

Not currently logged in
Email:
Password:

inflammatory disorders

This page shows the latest inflammatory disorders news and features for those working in and with pharma, biotech and healthcare.

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

anti-inflammatory drugs but have “considerable limitations”for patients with peripheral nerve damage. ... The three biosimilars are: Mylan’s Hulio (adalimumab), a version of AbbVie’s big-selling Humira for the treatment of certain inflammatory

Latest news

More from news
Approximately 1 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Opening up innovation Opening up innovation

    With over 1, 000 potential products being worked on, it's on a par with cardiovascular diseases and metabolic disorders in terms of research activity. ... immune-mediated inflammatory disorders.

  • Deal Watch January 2016 Deal Watch January 2016

    disorders. With a headline value of $102.25m, Receptor will be undertaking manufacture and commercialisation. ... 150. MannKind/ Receptor Life Sciences. Licence, collaboration. Multiple inhaled therapeutic products for conditions such as chronic pain,

  • Pharma deals during April 2014 Pharma deals during April 2014

    This gives Mallinckrodt, Acthar Gel (repository corticotropin), which is FDA approved for 19 “ difficult-to-treat” autoimmune and inflammatory associated conditions and currently primarily used to treat multiple sclerosis relapses, proteinuria

  • Pharma deals during March 2013 Pharma deals during March 2013

    25. Five Prime Therapeutics/ UCB. Option to license. Protein discovery platform - up to 5 programmes for fibrosis-related inflammatory diseases and CNS disorders.

  • Interview: Michel Goldman, Innovative Medicines Initiative Interview: Michel Goldman, Innovative Medicines Initiative

    And we do this by implementing proposals in different areas. For example, we have several projects on brain disorders, diabetes, cancer, inflammatory disorders and several projects on pulmonary diseases, to give ... His achievements in the fields of

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences

    He has 30 years’experience in research and development specifically in gastrointestinal disorders, inflammatory diseases and cancers, and previously co-founded Synergy Pharmaceuticals and served as its chief scientific officer.

  • Karus names two division heads Karus names two division heads

    Most recently he was VP, global head – respiratory disease. In his new role Dr Finan will work on Karus' most advanced programme, a treatment for inflammatory disorders.

  • Merck KGaA appoints biosimilar head Merck KGaA appoints biosimilar head

    From March 1, Sturge will run the company's biosimilars division, which was set up in 2012 to develop copies of biological treatments with a focus on oncology and inflammatory disorders.

  • Questcor appoints SVP corporate strategic development Questcor appoints SVP corporate strategic development

    His main responsibilities will include identifying potential partnerships and acquisitions for the company, which specialises in developing treatments for difficult-to-treat autoimmune and inflammatory disorders.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics